A preventative Alzheimer’s pill is the ideal end game for researchers studying the disease from many angles. While we’re not yet close to the goal, new research shows a way that it may be possible, using an approach similar to what has worked for managing other chronic conditions.
Scientists from the Baylor College of Medicine, Texas Children’s Hospital and Johns Hopkins University School of Medicine targeted ways of reducing the amount of toxic proteins that accumulate over years in the brains of those who subsequently develop Alzheimer’s. In a study published in the journal Neuron, the scientists report success in preventing the accumulation of these proteins, and the pathology they cause, in animal models.
